Johnson & Johnson

 

Lung
06:27

Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

FEATURING Mark A. Socinski, David Waterhouse
  • 549 views
  • May 21, 2024
  • 5
09:36

Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSCLC

FEATURING John Heymach, Millie Das
  • 487 views
  • May 21, 2024
  • 3
08:44

Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Locally Advanced or Metastatic EGFR+ NSCLC Treatment

FEATURING Joshua K. Sabari, Alexander Spira
  • 380 views
  • May 21, 2024
  • 1